Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
38181
CAS Number:
191217-81-9
Dichlorhydrate de pramipexole monohydraté
Purity:
≥ 98 % (HPLC)
Synonym(s):
( S )-2-Amino-4,5,6,7-tétrahydro-6-(propylamino)benzothiazoledichlorhydrate monohydraté, Dichlorhydrate de PPX monohydraté
Documents
$29.34 /100 mg
Taille
Request Bulk Quote
Informations sur le produit

Pramipexole dihydrochloride monohydrate is a potent dopamine agonist primarily used in the treatment of Parkinson's disease and restless legs syndrome. This compound acts by stimulating dopamine receptors in the brain, which helps to alleviate the symptoms associated with these neurological disorders. Its unique structure allows for effective penetration of the blood-brain barrier, making it a valuable therapeutic agent in managing motor control and reducing discomfort in patients.

In addition to its established medical applications, pramipexole dihydrochloride monohydrate is also being explored for potential uses in other neurological conditions, showcasing its versatility in research settings. Its favorable pharmacokinetic profile and relatively low side effect profile compared to other dopamine agonists make it a preferred choice among healthcare professionals. Researchers and industry professionals can leverage this compound for innovative studies aimed at understanding and treating various dopamine-related disorders, thus enhancing patient care and therapeutic outcomes.

Numéro CAS 
191217-81-9
Formule moléculaire
C10H17N3S · 2HCl · H2O
Poids moléculaire 
302.26
Point de fusion 
290 °C (déc.)
Rotation optique 
[a] D 20 = -65 à -71 ° (C=1 dans MeOH)
Informations générales
Numéro CAS 
191217-81-9
Formule moléculaire
C10H17N3S · 2HCl · H2O
Poids moléculaire 
302.26
Point de fusion 
290 °C (déc.)
Rotation optique 
[a] D 20 = -65 à -71 ° (C=1 dans MeOH)
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Pramipexole dihydrochloride monohydrate is widely utilized in research focused on:

  • Treatment of Parkinson's Disease: This compound is primarily used in the management of Parkinson's disease, helping to alleviate symptoms such as tremors and stiffness, thereby improving the quality of life for patients.
  • Restless Legs Syndrome (RLS): It is effective in treating RLS, providing relief from uncomfortable sensations in the legs, which can disrupt sleep and daily activities.
  • Neuroprotective Research: Researchers explore its neuroprotective properties, investigating its potential to protect neurons from damage, which could lead to advancements in treating neurodegenerative disorders.
  • Clinical Trials: The compound is frequently involved in clinical trials aimed at discovering new therapeutic uses, enhancing its role in pharmaceutical development.
  • Combination Therapies: It is often studied in combination with other medications to assess synergistic effects, potentially leading to more effective treatment regimens for various neurological conditions.

Citations